TCRX Past Earnings image   This TCRX past earnings page last updated 11/10/2022
TCRX Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/9/2022-0.670
Q2 20228/10/2022-0.630
Q1 20225/9/2022-0.670
Q4 20213/9/20220.380
Q3 202111/10/2021-0.800
Q2 20218/19/2021-7.690
TCRX Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/9/20220.00B
Q2 20228/10/20220.00B
Q1 20225/9/20220.00B
Q4 20213/9/20220.00B
Q3 202111/10/20210.00B
Q2 20218/19/20210.00B
Quotes delayed 20 minutes

Email EnvelopeFree TCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
TScan Therapeutics (TCRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

TDOC Past Earnings
TECH Past Earnings
TELA Past Earnings
TENX Past Earnings
TERN Past Earnings
TFFP Past Earnings
TFX Past Earnings
TGTX Past Earnings
THC Past Earnings
THMO Past Earnings

TCRX Past Earnings Q&A

What was the best and worst TCRX past earnings results?
For TScan Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest TCRX past earnings result in our data set was 0.380/share posted in Q4 2021, while the lowest was in Q2 2021 when TCRX posted -7.690/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when TCRX reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q3 2021 at 0.00B of revenue.

  Suggested answer: There are 6 TCRX past earnings results in our data set.

On this page we presented the TCRX past earnings date information for TScan Therapeutics. Reviewing that TCRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when TCRX posted gaap of 0.380/share. Meanwhile the lowest TCRX past earnings result was in Q2 2021, when TCRX posted gaap of -7.690/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when TCRX reported 0.00B in revenue, while the smallest revenue quarter was Q3 2021 when TCRX reported 0.00B in revenue.

Any self directed investor doing their due diligence on TCRX or any other given stock can benefit from researching all of the TScan Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate TScan Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TCRX. Thanks for visiting, and the next time you need to research TCRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of FF, OUNZ Videos, Funds Holding BOB.

 

TCRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.